Cargando…
Applications of an Equity Framework in COVID-19 Vaccine Trial and Distribution Planning
There are a disproportionate number of cases, hospitalizations, and deaths among Black and Latinx communities, a result of a history of structural racism and exploitation. An equity framework and approach are critical but have been lacking in the COVID-19 response, including vaccine dissemination. W...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804229/ https://www.ncbi.nlm.nih.gov/pubmed/35112047 http://dx.doi.org/10.1089/heq.2021.0122 |
_version_ | 1784643029801369600 |
---|---|
author | Davis, Alysia Mendez, Dara D. |
author_facet | Davis, Alysia Mendez, Dara D. |
author_sort | Davis, Alysia |
collection | PubMed |
description | There are a disproportionate number of cases, hospitalizations, and deaths among Black and Latinx communities, a result of a history of structural racism and exploitation. An equity framework and approach are critical but have been lacking in the COVID-19 response, including vaccine dissemination. We provide an overview and application of remove, repair, remediate, restructure, and provide (R4P), an equity framework, in examining COVID-19 vaccine trial development and related interventions. R4P is an equity framework and tool that applies critical race theory, intersectional, and dimensionality in planning, assessment, and research for creating action to eliminate inequities. |
format | Online Article Text |
id | pubmed-8804229 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Mary Ann Liebert, Inc., publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-88042292022-02-01 Applications of an Equity Framework in COVID-19 Vaccine Trial and Distribution Planning Davis, Alysia Mendez, Dara D. Health Equity Perspective There are a disproportionate number of cases, hospitalizations, and deaths among Black and Latinx communities, a result of a history of structural racism and exploitation. An equity framework and approach are critical but have been lacking in the COVID-19 response, including vaccine dissemination. We provide an overview and application of remove, repair, remediate, restructure, and provide (R4P), an equity framework, in examining COVID-19 vaccine trial development and related interventions. R4P is an equity framework and tool that applies critical race theory, intersectional, and dimensionality in planning, assessment, and research for creating action to eliminate inequities. Mary Ann Liebert, Inc., publishers 2022-01-25 /pmc/articles/PMC8804229/ /pubmed/35112047 http://dx.doi.org/10.1089/heq.2021.0122 Text en © Alysia Davis and Dara D. Mendez 2022; Published by Mary Ann Liebert, Inc. https://creativecommons.org/licenses/by/4.0/This Open Access article is distributed under the terms of the Creative Commons License [CC-BY] (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Perspective Davis, Alysia Mendez, Dara D. Applications of an Equity Framework in COVID-19 Vaccine Trial and Distribution Planning |
title | Applications of an Equity Framework in COVID-19 Vaccine Trial and Distribution Planning |
title_full | Applications of an Equity Framework in COVID-19 Vaccine Trial and Distribution Planning |
title_fullStr | Applications of an Equity Framework in COVID-19 Vaccine Trial and Distribution Planning |
title_full_unstemmed | Applications of an Equity Framework in COVID-19 Vaccine Trial and Distribution Planning |
title_short | Applications of an Equity Framework in COVID-19 Vaccine Trial and Distribution Planning |
title_sort | applications of an equity framework in covid-19 vaccine trial and distribution planning |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804229/ https://www.ncbi.nlm.nih.gov/pubmed/35112047 http://dx.doi.org/10.1089/heq.2021.0122 |
work_keys_str_mv | AT davisalysia applicationsofanequityframeworkincovid19vaccinetrialanddistributionplanning AT mendezdarad applicationsofanequityframeworkincovid19vaccinetrialanddistributionplanning |